- Home
- BMY vs MO Comparison
BMY vs MO Comparison
Compare BMY & MO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- MO
- Stock Information
- Founded
- BMY 1887
- MO 1822
- Country
- BMY United States
- MO United States
- Employees
- BMY N/A
- MO N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- MO Medicinal Chemicals and Botanical Products
- Sector
- BMY Health Care
- MO Health Care
- Exchange
- BMY Nasdaq
- MO Nasdaq
- Market Cap
- BMY 110.2B
- MO 95.4B
- IPO Year
- BMY N/A
- MO N/A
- Fundamental
- Price
- BMY $58.21
- MO $55.85
- Analyst Decision
- BMY Hold
- MO Hold
- Analyst Count
- BMY 14
- MO 6
- Target Price
- BMY $53.92
- MO $51.33
- AVG Volume (30 Days)
- BMY 11.9M
- MO 8.0M
- Earning Date
- BMY 10-31-2024
- MO 10-31-2024
- Dividend Yield
- BMY 4.11%
- MO 7.29%
- EPS Growth
- BMY N/A
- MO 20.56
- EPS
- BMY N/A
- MO 5.91
- Revenue
- BMY $47,435,000,000.00
- MO $20,362,000,000.00
- Revenue This Year
- BMY $6.54
- MO $2.38
- Revenue Next Year
- BMY N/A
- MO N/A
- P/E Ratio
- BMY N/A
- MO $9.45
- Revenue Growth
- BMY 5.56
- MO N/A
- 52 Week Low
- BMY $39.35
- MO $39.25
- 52 Week High
- BMY $61.08
- MO $56.55
- Technical
- Relative Strength Index (RSI)
- BMY 61.07
- MO 70.11
- Support Level
- BMY $55.82
- MO $53.78
- Resistance Level
- BMY $59.73
- MO $56.55
- Average True Range (ATR)
- BMY 1.67
- MO 1.03
- MACD
- BMY 0.11
- MO 0.27
- Stochastic Oscillator
- BMY 61.84
- MO 86.56
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MO Altria Group Inc.
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2023. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev, a 42% stake in cannabis manufacturer Cronos, acquired Njoy Holdings in 2023, and operates a joint venture with Japan Tobacco in the heated tobacco category. It also recently disposed of its investment in Juul Labs.